Pharmacokinetic Study of Oral ALXN1840 in Japanese and Non-Japanese Adult Healthy Participants

NCT05641311 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Wilson Disease

Interventions

DRUG: ALXN1840

Sponsor

Alexion Pharmaceuticals, Inc.